Dap-ug, Jellfe E.

HRN: 22-12-30  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/30/2022
CEFTRIAXONE 1G (VIAL)
10/30/2022
11/06/2022
IV
2gm
Q24hours
Acute Appendicitis
Waiting Final Action 
10/30/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/30/2022
11/06/2022
IV
500mg
Q8hour
Acute Appendicitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: